EPRS1
Basic information
Region (hg38): 1:219968600-220046530
Previous symbols: [ "QPRS", "QARS", "EPRS" ]
Links
Phenotypes
GenCC
Source:
- leukodystrophy, hypomyelinating, 15 (Strong), mode of inheritance: AR
- leukodystrophy, hypomyelinating, 15 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukodystrophy, hypomyelinating, 15 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Neurologic; Ophthalmologic | 29576217 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (303 variants)
- Inborn_genetic_diseases (157 variants)
- Leukodystrophy,_hypomyelinating,_15 (29 variants)
- EPRS1-related_disorder (29 variants)
- not_specified (2 variants)
- Global_developmental_delay (1 variants)
- Intellectual_disability (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPRS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004446.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 74 | 82 | ||||
missense | 236 | 19 | 269 | |||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 15 | 4 | 237 | 93 | 15 |
Highest pathogenic variant AF is 0.00000805535
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EPRS1 | protein_coding | protein_coding | ENST00000366923 | 32 | 78058 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.04e-9 | 1.00 | 125664 | 0 | 84 | 125748 | 0.000334 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.60 | 669 | 796 | 0.841 | 0.0000402 | 9951 |
Missense in Polyphen | 207 | 293.17 | 0.70607 | 3441 | ||
Synonymous | -1.54 | 301 | 269 | 1.12 | 0.0000136 | 2785 |
Loss of Function | 5.28 | 31 | 82.9 | 0.374 | 0.00000420 | 1037 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000743 | 0.000741 |
Ashkenazi Jewish | 0.000202 | 0.000198 |
East Asian | 0.000440 | 0.000435 |
Finnish | 0.000234 | 0.000231 |
European (Non-Finnish) | 0.000275 | 0.000273 |
Middle Eastern | 0.000440 | 0.000435 |
South Asian | 0.000574 | 0.000523 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Multifunctional protein which is primarily part of the aminoacyl-tRNA synthetase multienzyme complex, also know as multisynthetase complex, that catalyzes the attachment of the cognate amino acid to the corresponding tRNA in a two-step reaction: the amino acid is first activated by ATP to form a covalent intermediate with AMP and is then transferred to the acceptor end of the cognate tRNA (PubMed:1756734, PubMed:24100331, PubMed:23263184). The phosphorylation of EPRS, induced by interferon-gamma, dissociates the protein from the aminoacyl-tRNA synthetase multienzyme complex and recruits it to the GAIT complex that binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin), suppressing their translation. Interferon-gamma can therefore redirect, in specific cells, the EPRS function from protein synthesis to translation inhibition (PubMed:15479637, PubMed:23071094). Also functions as an effector of the mTORC1 signaling pathway by promoting, through SLC27A1, the uptake of long-chain fatty acid by adipocytes. Thereby, it also plays a role in fat metabolism and more indirectly influences lifespan (PubMed:28178239). {ECO:0000269|PubMed:15479637, ECO:0000269|PubMed:1756734, ECO:0000269|PubMed:23071094, ECO:0000269|PubMed:23263184, ECO:0000269|PubMed:24100331, ECO:0000269|PubMed:28178239}.;
- Disease
- DISEASE: Leukodystrophy, hypomyelinating, 15 (HLD15) [MIM:617951]: An autosomal recessive disorder characterized by hypomyelinating leukodystrophy with thinning of the corpus callosum. Clinical features include motor and cognitive impairment appearing in the first or second decade of life, dystonia, ataxia, spasticity, and dysphagia. Most patients develop severe optic atrophy, and some have hearing loss. {ECO:0000269|PubMed:29576217}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Parkinsons Disease Pathway;Amino Acid metabolism;tRNA modification in the nucleus and cytosol;tRNA processing;tRNA Aminoacylation;Translation;Glutamate Glutamine metabolism;Metabolism of proteins;Metabolism of amino acids and derivatives;Metabolism of RNA;TCR;Metabolism;tRNA charging;Selenoamino acid metabolism;Arginine Proline metabolism;SeMet incorporation into proteins;Cytosolic tRNA aminoacylation
(Consensus)
Recessive Scores
- pRec
- 0.529
Intolerance Scores
- loftool
- 0.778
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 44.11
Haploinsufficiency Scores
- pHI
- 0.826
- hipred
- Y
- hipred_score
- 0.644
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.985
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eprs
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype;
Gene ontology
- Biological process
- tRNA aminoacylation for protein translation;glutamyl-tRNA aminoacylation;prolyl-tRNA aminoacylation;negative regulation of translation;cellular response to insulin stimulus;long-chain fatty acid import;protein-containing complex assembly;cellular response to interferon-gamma
- Cellular component
- cytoplasm;cytosol;plasma membrane;membrane;aminoacyl-tRNA synthetase multienzyme complex;GAIT complex;ribonucleoprotein complex
- Molecular function
- glutamate-tRNA ligase activity;proline-tRNA ligase activity;protein binding;ATP binding;zinc ion binding;RNA stem-loop binding;identical protein binding;protein homodimerization activity;GTPase binding